LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.83 | 21.74 | 1230 | 2110 | 0.5829 | 0.8430 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.83 | 21.74 | 1346 | 2110 | 0.6379 | 0.8683 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.83 | 21.74 | 1388 | 2110 | 0.6578 | 0.8770 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.83 | 21.74 | 1450 | 2110 | 0.6872 | 0.8895 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.80 | 21.74 | 1327 | 2381 | 0.5572 | 0.8346 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.80 | 21.74 | 1437 | 2381 | 0.6034 | 0.8563 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.80 | 21.74 | 1485 | 2381 | 0.6236 | 0.8653 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.80 | 21.74 | 1535 | 2381 | 0.6446 | 0.8745 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.77 | 21.74 | 1399 | 2602 | 0.5375 | 0.8280 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.77 | 21.74 | 1516 | 2602 | 0.5824 | 0.8494 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.77 | 21.74 | 1556 | 2602 | 0.5978 | 0.8564 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.77 | 21.74 | 1613 | 2602 | 0.6197 | 0.8661 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.74 | 21.74 | 1454 | 2828 | 0.5141 | 0.8192 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.74 | 21.74 | 1579 | 2828 | 0.5583 | 0.8407 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.74 | 21.74 | 1639 | 2828 | 0.5795 | 0.8505 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.74 | 21.74 | 1701 | 2828 | 0.6014 | 0.8603 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.71 | 21.74 | 1576 | 3084 | 0.5110 | 0.8207 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.71 | 21.74 | 1682 | 3084 | 0.5454 | 0.8374 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.71 | 21.74 | 1739 | 3084 | 0.5639 | 0.8460 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.71 | 21.74 | 1793 | 3084 | 0.5814 | 0.8539 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.68 | 21.74 | 1659 | 3418 | 0.4853 | 0.8113 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.68 | 21.74 | 1774 | 3418 | 0.5189 | 0.8280 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.68 | 21.74 | 1805 | 3418 | 0.5280 | 0.8324 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.68 | 21.74 | 1864 | 3418 | 0.5452 | 0.8405 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.65 | 21.74 | 1769 | 3754 | 0.4712 | 0.8074 | MN20160310_N01 | E05 |